NME Candidates For 2012 Have Modest Ambitions; Standard Reviews And Small Molecules Dominate
By
Bridget Silverman / Email the Author / “The Pink Sheet” Jan. 30, 2012, Vol. 74, No. 5
Year In Review And The Year Ahead / Word Count: 3079 / Article # 00120130023
Executive Summary
With the same range of novel product submissions as in 2011, the year ahead could reach an equally healthy tally of new molecular and novel biological entity approvals. But a look at upcoming applications suggests that the makeup of those classes could be very different.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.